My break-even exit is 10.5c, so in the event of rejection by the FDA I would expect to be able to exit pretty much on the day.FDA was our aim in 2017 but the trial results were not fit for purpose so we didn't proceed. Saying it's not a failure because we decided not to proceed is a matter of semantics. The reality is in the share price action at the time.
FDA was our aim in 2017 but the trial results were not fit for...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 872 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)